These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 35594744)

  • 1. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
    Kılıç B; Serdaroğlu E; Polat BG; İnce T; Esenülkü G; Topçu Y; Serdaroğlu A; Haspolat Ş; Tekgül H; Okuyaz Ç; Cansu A; Aydın K
    Seizure; 2022 Jul; 99():48-53. PubMed ID: 35594744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
    Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS
    Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
    Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
    Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A; Brodie MJ
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
    Tabrizi N; Zarvani A; Rezaei P; Cheraghmakani H; Alizadeh-Navaei R
    Epilepsy Res; 2019 Nov; 157():106214. PubMed ID: 31627041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.
    Gürer R; Aydın Ş; Özkara Ç
    Seizure; 2019 Aug; 70():43-48. PubMed ID: 31252363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy.
    Ascoli M; Mastroianni G; Gasparini S; Striano P; Cianci V; Neri S; Bova V; Mammì A; Gambardella A; Labate A; Aguglia U; Ferlazzo E
    Expert Rev Neurother; 2021 Nov; 21(11):1265-1273. PubMed ID: 33993822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication.
    Cerulli Irelli E; Cocchi E; Morano A; Gesche J; Caraballo RH; Lattanzi S; Strigaro G; Rosati E; Catania C; Ferlazzo E; Casciato S; Di Gennaro G; Pizzanelli C; Giuliano L; Viola V; Mostacci B; Pignatta P; Fortunato F; Pulitano P; Panzini C; Gambardella A; Atalar AÇ; Labate A; Operto FF; Giallonardo AT; Baykan BB; Beier CP; Di Bonaventura C;
    Neurology; 2024 May; 102(9):e209222. PubMed ID: 38569127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
    Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI
    Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center.
    Cação G; Parra J; Mannan S; Sisodiya SM; Sander JW
    Epilepsy Behav; 2018 May; 82():81-86. PubMed ID: 29602081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of juvenile myoclonic epilepsy.
    Auvin S
    CNS Neurosci Ther; 2008; 14(3):227-33. PubMed ID: 18684236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy.
    Johannessen Landmark C; Fløgstad I; Baftiu A; Syvertsen M; Enger U; Koht J; Johannessen SI
    Epilepsy Res; 2019 Sep; 155():106148. PubMed ID: 31195184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study.
    van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
    Neurology; 2022 Sep; 99(10):e999-e1008. PubMed ID: 36219797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam monotherapy in juvenile myoclonic epilepsy.
    Sharpe DV; Patel AD; Abou-Khalil B; Fenichel GM
    Seizure; 2008 Jan; 17(1):64-8. PubMed ID: 17692537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure outcome trajectories in a well-defined cohort of newly diagnosed juvenile myoclonic epilepsy patients.
    Cerulli Irelli E; Morano A; Orlando B; Salamone EM; Fanella M; Fattouch J; Manfredi M; Giallonardo AT; Di Bonaventura C
    Acta Neurol Scand; 2022 Mar; 145(3):314-321. PubMed ID: 34791656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.
    Liguori C; Turner K; Izzi F; Assogna M; Canevini MP; Mercuri NB; Placidi F
    CNS Neurosci Ther; 2019 May; 25(5):632-637. PubMed ID: 30675751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in prescription of anti-seizure medications in Japan between 2018 and 2021: A retrospective study using the National Database Open Data Japan.
    Ura H; Matsuoka N; Kubota K; Sadamoto K
    Epilepsy Behav; 2024 Oct; 159():109949. PubMed ID: 39121754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
    Calleja S; Salas-Puig J; Ribacoba R; Lahoz CH
    Seizure; 2001 Sep; 10(6):424-7. PubMed ID: 11700996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.